Great Point Partners (GPP) has announced the acquisition of a majority stake in Eutecma.
Eutecma, founded in 2008 and based in Germany, is a developer of temperature-controlled packaging solutions for pharmaceutical cold chain shipments. The company has refreshment centers in the United States and European Union.
GPP, founded in 2003 and based in Greenwich, Conn., is a private investment firm focused on the healthcare industry. The firm targets investments in biopharmaceutical supply chain services and products; healthcare services; healthcare information technology-enabled services; and medical devices and diagnostics in businesses operating in the United States, Canada and Western Europe. GPP pursues lower middle market companies generating between $10 million and $100 million of revenue and $2 million to $12 million of EBITDA.
Terms of the transaction were not disclosed.
